Table 2.
Patients clinical characteristics.
| Overall (N = 69) | non-CMS (N = 47) | CMS (N = 22) | p-Value | ||
|---|---|---|---|---|---|
| Sex, n (%) | Female | 26 (37.7) | 24 (51.1) | 2 (9.1) | 0.002 |
| Male | 43 (62.3) | 23 (48.9) | 20 (90.9) | ||
| Age at surgery, mean (SD) | 6.0 (3.4) | 5.8 (3.4) | 6.2 (3.2) | 0.649 | |
| Tumors size, mean (SD) | 48.4 (12.7) | 46.2 (14.4) | 53.2 (6.0) | 0.006 | |
| Hydrocephalus, n (%) | No | 28 (40.6) | 25 (53.2) | 3 (13.6) | 0.004 |
| Yes | 41 (59.4) | 22 (46.8) | 19 (86.4) | ||
| Midline location, n (%) | No | 14 (20.3) | 14 (29.8) | 0 (0) | 0.003 |
| Yes | 55 (79.7) | 33 (70.2) | 22 (100.0) | ||
| VP shunt, n (%) | No | 56 (81.2) | 34 (72.3) | 22 (100.0) | 0.006 |
| Yes | 13 (18.8) | 13 (27.7) | |||
| EOR, n (%) | No | 10 (14.5) | 3 (6.4) | 7 (31.8) | 0.009 |
| Yes | 59 (85.5) | 44 (93.6) | 15 (68.2) | ||
| Pathology, n (%) | EP | 9 (13.0) | 3 (6.4) | 6 (27.3) | <0.001 |
| MB | 25 (36.2) | 10 (21.3) | 15 (68.2) | ||
| Other | 35 (50.7) | 34 (72.3) | 1 (4.5) | ||
| WHO grade, n (%) | Low | 34 (49.3) | 17 (36.2) | 17 (77.3) | 0.003 |
| High | 35 (50.7) | 30 (63.8) | 5 (22.7) | ||
| Oropharyngeal dysfunction, n (%) | No | 53 (76.8) | 45 (95.7) | 8 (36.4) | <0.001 |
| Yes | 16 (23.2) | 2 (4.3) | 14 (63.6) | ||
| Behavior change, n (%) | No | 36 (52.2) | 33 (70.2) | 3 (13.6) | <0.001 |
| Yes | 33 (47.8) | 14 (29.8) | 19 (86.4) | ||
| Radiotherapy | No | 37 (53.6) | 20 (42.6) | 17 (77.3) | 0.015 |
| Yes | 32 (46.4) | 27 (57.4) | 5 (22.7) | ||
| Chemotherapy | No | 35 (50.7) | 19 (40.4) | 16 (72.7) | 0.025 |
| Yes | 34 (49.3) | 28 (59.6) | 6 (27.3) | ||
| Time since surgery, mean (SD) | 45.2 (16.7) | 42.2 (17.5) | 51.6 (12.7) | 0.015 |
CMS, cerebellar mutism syndrome; VP shunt, ventriculoperitoneal shunt; EOR, extent of resection.